/
/
/

Ajanta Pharma Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014
₹1626 Cr₹1422 Cr₹1375 Cr₹1354 Cr₹1303 Cr₹1170 Cr₹1146 Cr₹1187 Cr₹1145 Cr₹1054 Cr₹1105 Cr₹1028 Cr₹1021 Cr₹882 Cr₹972 Cr₹938 Cr₹951 Cr₹870 Cr₹838 Cr₹885 Cr₹748 Cr₹757 Cr₹749 Cr₹716 Cr₹668 Cr₹682 Cr₹651 Cr₹643 Cr₹612 Cr₹515 Cr₹485 Cr₹544 Cr₹511 Cr₹530 Cr₹587 Cr₹540 Cr₹473 Cr₹477 Cr₹533 Cr₹516 Cr₹476 Cr₹431 Cr₹477 Cr₹442 Cr₹391 Cr₹372 Cr₹408 Cr₹372 Cr₹322 Cr
₹71 Cr₹61 Cr₹25 Cr₹59 Cr₹26 Cr₹18 Cr₹30 Cr₹19 Cr₹26 Cr₹36 Cr₹14 Cr₹21 Cr₹32 Cr₹37 Cr₹35 Cr₹40 Cr₹33 Cr₹29 Cr₹24 Cr₹30 Cr₹33 Cr₹3 Cr₹5 Cr₹5 Cr₹13 Cr₹57 Cr₹15 Cr₹13 Cr₹8 Cr₹2 Cr₹4 Cr₹15 Cr₹8 Cr₹5 Cr₹15 Cr₹9 Cr₹5 Cr₹6 Cr₹19 Cr₹7 Cr₹5 Cr₹5 Cr₹2 Cr₹6 Cr₹8 Cr₹5 Cr₹5 Cr₹4 Cr₹5 Cr
₹1697 Cr₹1483 Cr₹1400 Cr₹1413 Cr₹1329 Cr₹1189 Cr₹1177 Cr₹1206 Cr₹1171 Cr₹1090 Cr₹1119 Cr₹1050 Cr₹1053 Cr₹919 Cr₹1007 Cr₹978 Cr₹984 Cr₹900 Cr₹862 Cr₹914 Cr₹781 Cr₹759 Cr₹754 Cr₹721 Cr₹681 Cr₹739 Cr₹666 Cr₹656 Cr₹620 Cr₹517 Cr₹490 Cr₹559 Cr₹519 Cr₹536 Cr₹602 Cr₹550 Cr₹478 Cr₹483 Cr₹552 Cr₹522 Cr₹481 Cr₹436 Cr₹479 Cr₹448 Cr₹399 Cr₹377 Cr₹412 Cr₹376 Cr₹326 Cr
₹1247 Cr₹1134 Cr₹1036 Cr₹1069 Cr₹993 Cr₹913 Cr₹861 Cr₹910 Cr₹849 Cr₹810 Cr₹825 Cr₹771 Cr₹783 Cr₹765 Cr₹836 Cr₹774 Cr₹761 Cr₹695 Cr₹630 Cr₹654 Cr₹559 Cr₹528 Cr₹536 Cr₹470 Cr₹473 Cr₹557 Cr₹489 Cr₹488 Cr₹466 Cr₹407 Cr₹396 Cr₹395 Cr₹371 Cr₹407 Cr₹405 Cr₹371 Cr₹359 Cr₹338 Cr₹371 Cr₹357 Cr₹323 Cr₹300 Cr₹325 Cr₹299 Cr₹279 Cr₹252 Cr₹276 Cr₹256 Cr₹237 Cr
₹494 Cr₹395 Cr₹407 Cr₹387 Cr₹378 Cr₹315 Cr₹351 Cr₹331 Cr₹357 Cr₹314 Cr₹328 Cr₹312 Cr₹303 Cr₹186 Cr₹204 Cr₹237 Cr₹255 Cr₹236 Cr₹264 Cr₹292 Cr₹253 Cr₹262 Cr₹247 Cr₹279 Cr₹236 Cr₹208 Cr₹201 Cr₹191 Cr₹176 Cr₹129 Cr₹112 Cr₹181 Cr₹166 Cr₹145 Cr₹213 Cr₹193 Cr₹132 Cr₹163 Cr₹197 Cr₹179 Cr₹171 Cr₹147 Cr₹166 Cr₹160 Cr₹130 Cr₹138 Cr₹149 Cr₹133 Cr₹101 Cr
₹3 Cr₹2 Cr₹5 Cr₹3 Cr₹5 Cr₹6 Cr₹8 Cr₹6 Cr₹73 L₹2 Cr₹2 Cr₹2 Cr₹85 L₹1 Cr₹3 Cr₹99 L₹88 L₹7 Cr₹95 L₹40 L₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹4 Cr₹2 Cr₹5 Cr₹2 Cr₹77 L₹9 L₹13 L₹17 L₹11 L₹14 L₹9 L₹7 L₹39 L₹28 L₹29 L₹40 L₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr
₹447 Cr₹347 Cr₹359 Cr₹341 Cr₹331 Cr₹269 Cr₹307 Cr₹290 Cr₹322 Cr₹278 Cr₹291 Cr₹276 Cr₹269 Cr₹152 Cr₹168 Cr₹203 Cr₹222 Cr₹198 Cr₹231 Cr₹260 Cr₹220 Cr₹229 Cr₹215 Cr₹249 Cr₹207 Cr₹176 Cr₹175 Cr₹162 Cr₹151 Cr₹109 Cr₹93 Cr₹164 Cr₹148 Cr₹128 Cr₹198 Cr₹178 Cr₹119 Cr₹144 Cr₹181 Cr₹165 Cr₹158 Cr₹134 Cr₹153 Cr₹148 Cr₹119 Cr₹115 Cr₹135 Cr₹119 Cr₹87 Cr
₹334 Cr₹267 Cr₹274 Cr₹260 Cr₹255 Cr₹225 Cr₹233 Cr₹216 Cr₹246 Cr₹203 Cr₹210 Cr₹195 Cr₹208 Cr₹122 Cr₹135 Cr₹157 Cr₹175 Cr₹151 Cr₹192 Cr₹196 Cr₹174 Cr₹159 Cr₹177 Cr₹170 Cr₹148 Cr₹129 Cr₹108 Cr₹116 Cr₹115 Cr₹89 Cr₹67 Cr₹125 Cr₹106 Cr₹94 Cr₹147 Cr₹132 Cr₹95 Cr₹114 Cr₹143 Cr₹131 Cr₹120 Cr₹109 Cr₹114 Cr₹103 Cr₹86 Cr₹74 Cr₹93 Cr₹83 Cr₹60 Cr

Share Price Live Stats

Open (₹)3,503.50
Volume (₹)11,203.00
High (₹)3,521.10
Upper Circuit4,225.30
Low (₹)3,455.30
Lower Circuit2,816.90
Prev Close3,521.10
52W High (₹)3,796.00
Price3,467.50
52W Low (₹)2,329.90

Share Market Cap & Key Ratios Overview

M.Cap (₹)44001.20 Cr
Div. Yield (%)0.80
PE Ratio38.77
Debt to Equity0.05
Price to Book7.74
Book Value362.19
EPS (TTM)90.82
Face Value2.00
ROE (%)25.42

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
AJANTPHARMNSE
LTP
1W Low
1W High
Market cap (₹)
1904.7-15.3 (-0.80%)
1902
1984.80
4,56,833Cr
9188.5-50.5 (-0.55%)
9087
9467
2,45,426Cr
4902-148 (-2.93%)
4886.50
5066
1,87,320Cr
1133.6-57.4 (-4.82%)
1125.10
1187
1,13,217Cr
1390-33.5 (-2.35%)
1376.70
1426.10
1,12,212Cr
1853.1-85.4 (-4.41%)
1811.70
1949
1,01,155Cr
2126.4-45.1 (-2.08%)
2118.10
2192
97,626Cr
2351.8-31.1 (-1.31%)
2341.20
2419.20
96,859Cr
1164.5-13.5 (-1.15%)
1154.40
1179.90
96,406Cr
1654.7+9.4 (0.57%)
1622.60
1717
93,614Cr
3467.5-89.5 (-2.52%)
3425
3666
44,001Cr

Key Highlights of Ajanta Pharma Ltd’s P&L

In 2026-03-31, Ajanta Pharma Ltd reported total revenue of ₹5624.93Cr, compared with ₹4742.6Cr in 2025-03-31, reflecting Ajanta Pharma Ltd turnover.

Depreciation was ₹173.14Cr and finance costs were ₹16.11Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹1377.65Cr in 2026-03-31 as compared to ₹1189.16Cr in 2025-03-31.

Net Profit (PAT) was ₹1056Cr in 2026-03-31 compared with ₹920.39Cr in 2025-03-31.

Earnings per share (EPS) were ₹84.55 in 2026-03-31, compared with ₹73.69 in 2025-03-31.